NASDAQ:AIPT - Precision Therapeutics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.16 -0.02 (-1.69 %)
(As of 08/20/2018 04:00 PM ET)
Previous Close$1.18
Today's Range$1.16 - $1.26
52-Week Range$0.81 - $2.50
Volume87,600 shs
Average Volume529,684 shs
Market Capitalization$14.52 million
P/E RatioN/A
Dividend YieldN/A
Beta1.09
Precision Therapeutics Inc. provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables. The company also provides contract research organization (CRO) that offers personalized medicine solutions for pharmaceutical, diagnostic, and biotech industries. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence applied to diseases databases. The company markets and sells its STREAMWAY Fluid Waste Management system and procedure disposables to medical facilities through various direct sales force and independent distributors. The company was formerly known as Skyline Medical Inc. and changed its name to Precision Therapeutics Inc. in February 2018. Precision Therapeutics Inc. was founded in 2002 and is based in Eagan, Minnesota.

Receive AIPT News and Ratings via Email

Sign-up to receive the latest news and ratings for AIPT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AIPT
CUSIPN/A
Phone651-389-4800

Debt

Debt-to-Equity RatioN/A
Current Ratio4.00
Quick Ratio3.65

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$650,000.00
Price / Sales23.91
Cash FlowN/A
Price / CashN/A
Book Value$0.24 per share
Price / Book4.83

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-7,740,000.00
Net Margins-915.36%
Return on Equity-244.46%
Return on Assets-185.25%

Miscellaneous

Employees17
Outstanding Shares13,400,000
Market Cap$14.52 million

Precision Therapeutics (NASDAQ:AIPT) Frequently Asked Questions

What is Precision Therapeutics' stock symbol?

Precision Therapeutics trades on the NASDAQ under the ticker symbol "AIPT."

How were Precision Therapeutics' earnings last quarter?

Precision Therapeutics Inc (NASDAQ:AIPT) released its earnings results on Tuesday, August, 14th. The medical instruments supplier reported ($0.20) earnings per share for the quarter. The medical instruments supplier had revenue of $0.36 million for the quarter. Precision Therapeutics had a negative net margin of 915.36% and a negative return on equity of 244.46%. View Precision Therapeutics' Earnings History.

When is Precision Therapeutics' next earnings date?

Precision Therapeutics is scheduled to release their next quarterly earnings announcement on Tuesday, November, 13th 2018. View Earnings Estimates for Precision Therapeutics.

Who are some of Precision Therapeutics' key competitors?

Who are Precision Therapeutics' key executives?

Precision Therapeutics' management team includes the folowing people:
  • Dr. Carl I. Schwartz, CEO, Director & Member of Medical Advisory Board (Age 77)
  • Mr. Robert L. Myers, CFO & Sec. (Age 63)
  • Mr. David Orrin Johnson, Chief Operating Officer (Age 65)
  • Mr. Kevin Hungerford, VP of Sales & Marketing
  • Mr. David Dauwalter, Director of Product Management

Has Precision Therapeutics been receiving favorable news coverage?

News articles about AIPT stock have trended somewhat negative on Monday, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Precision Therapeutics earned a news impact score of -0.15 on Accern's scale. They also assigned media stories about the medical instruments supplier an impact score of 41.11 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future. View Recent Headlines for Precision Therapeutics.

How do I buy shares of Precision Therapeutics?

Shares of AIPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Precision Therapeutics' stock price today?

One share of AIPT stock can currently be purchased for approximately $1.16.

How big of a company is Precision Therapeutics?

Precision Therapeutics has a market capitalization of $14.52 million and generates $650,000.00 in revenue each year. Precision Therapeutics employs 17 workers across the globe.

How can I contact Precision Therapeutics?

Precision Therapeutics' mailing address is 2915 COMMERS DRIVE SUITE 900, EAGAN MN, 55121. The medical instruments supplier can be reached via phone at 651-389-4800 or via email at [email protected]


MarketBeat Community Rating for Precision Therapeutics (NASDAQ AIPT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  63 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  123
MarketBeat's community ratings are surveys of what our community members think about Precision Therapeutics and other stocks. Vote "Outperform" if you believe AIPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AIPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel